Cargando…

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation

BACKGROUND: POLE is a critical biomarker for endometrial cancer (ECs) prognosis and therapeutic decision. However, the immune infiltration and immunotherapy-related gene expression in the tumor microenvironment (TME) of POLE-mutated ECs remain unresolved. METHODS: The TCGA database was used to chara...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tieyan, Yu, Dan, Wang, Juanjuan, Zhu, Ningning, Tang, Xian-bin, Chen, Xiuwen, Su, Xiao-min, Huang, Yu-gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652564/ https://www.ncbi.nlm.nih.gov/pubmed/38023184 http://dx.doi.org/10.3389/fonc.2023.1250558

Ejemplares similares

The role of TCGA molecular classification in clear cell endometrial carcinoma
por: Tang, Xinyue, et al.
Publicado: (2023)

In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries
por: Das Ghosh, Damayanti, et al.
Publicado: (2023)

Phenotype of POLE-mutated endometrial cancer
por: Imboden, Sara, et al.
Publicado: (2019)

POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy
por: Dong, Dandan, et al.
Publicado: (2021)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

Systematic Identification of Multi Omics-based Biomarkers in KEAP1 Mutated TCGA Lung Adenocarcinoma
por: Namani, Akhileshwar, et al.
Publicado: (2019)

Molecular Features of Glioma Determined and Validated Using Combined TCGA and GTEx Data Analyses
por: Yang, Zijiang, et al.
Publicado: (2021)

Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data
por: Cui, Yishuang, et al.
Publicado: (2023)

Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases
por: Han, Zhijun, et al.
Publicado: (2022)

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
por: Church, David N., et al.
Publicado: (2014)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015)

A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report
por: Cui, Jiantao, et al.
Publicado: (2023)

Development and Validation of a Nomogram for Preoperative Prediction of Lymph Node Metastasis in Lung Adenocarcinoma Based on Radiomics Signature and Deep Learning Signature
por: Ran, Jia, et al.
Publicado: (2021)

Identification of Methylation-Regulated Differentially Expressed Genes and Related Pathways in Hepatocellular Carcinoma: A Study Based on TCGA Database and Bioinformatics Analysis
por: Liang, Yu, et al.
Publicado: (2021)

A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction
por: Niu, Xuegang, et al.
Publicado: (2020)

POLE exonuclease domain mutations in endometrial carcinoma: a case report
por: Pasciuto, Maria Paola, et al.
Publicado: (2023)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
por: Ye, Dingde, et al.
Publicado: (2021)

Identification of a Metabolism-Related Signature for the Prediction of Survival in Endometrial Cancer Patients
por: Fan, Yuan, et al.
Publicado: (2021)

ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer
por: Gu, Jiahui, et al.
Publicado: (2023)

Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma
por: Guo, Chenrui, et al.
Publicado: (2022)

Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2022)

Integrated Bioinformatic Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Endometrial Cancer
por: Xia, Leilei, et al.
Publicado: (2019)

An Efficacious Endometrial Sampler for Screening Endometrial Cancer
por: Han, Lu, et al.
Publicado: (2019)

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study
por: Yu, Shuangni, et al.
Publicado: (2022)

GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data
por: Xu, Su-Mei, et al.
Publicado: (2023)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
por: Wei, Sitian, et al.
Publicado: (2022)

Development and validation of a prognostic 9-gene signature for colorectal cancer
por: Cui, Junpeng, et al.
Publicado: (2022)

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability
por: Haruma, Tomoko, et al.
Publicado: (2018)

High Expression of the SH3TC2-DT/SH3TC2 Gene Pair Associated With FLT3 Mutation and Poor Survival in Acute Myeloid Leukemia: An Integrated TCGA Analysis
por: Yu, Pengfei, et al.
Publicado: (2020)

Case report: POLE (P286R) mutation in a case of recurrent intestinal leakage and its treatment
por: Xiang, Dang, et al.
Publicado: (2023)

Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
por: Huang, Yugang, et al.
Publicado: (2021)

Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma
por: Chen, Jialu, et al.
Publicado: (2022)

Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis
por: Wang, Jun, et al.
Publicado: (2020)

Validation of Molecular Typing for Endometrial Screening Test That Predicts Benign and Malignant Lesions
por: Tuo, Xiaoqian, et al.
Publicado: (2019)

A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival
por: Tian, Baoxing, et al.
Publicado: (2021)

Mechanical Stimulus-Related Risk Signature Plays a Key Role in the Prognostic Nomogram For Endometrial Cancer
por: Xu, Xin, et al.
Publicado: (2021)

Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
por: Zhong, Jianxin, et al.
Publicado: (2023)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
por: Gu, Hongmei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ev96hueu7db7jkefljrl7km5sk